Anthem Biosciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.06 | 0.08 | 0.05 | 0.07 | 0.23 |
Long Term Debt-Equity Ratio | 0.03 | 0.04 | 0.03 | 0.01 | 0.10 |
Current Ratio | 3.76 | 4.13 | 4.50 | 2.48 | 1.38 |
Fixed Assets | 1.67 | 1.51 | 1.33 | 1.77 | 1.77 |
Inventory | 6.69 | 8.32 | 11.26 | 26.40 | 13.75 |
Debtors | 3.93 | 3.71 | 3.52 | 4.24 | 6.13 |
Interest Cover Ratio | 77.58 | 53.35 | 51.97 | 55.17 | 22.54 |
PBIDTM (%) | 43.39 | 40.60 | 48.86 | 49.90 | 40.33 |
PBITM (%) | 39.16 | 34.85 | 42.83 | 45.21 | 34.68 |
PBDTM (%) | 42.88 | 39.95 | 48.03 | 49.08 | 38.79 |
CPM (%) | 31.73 | 32.19 | 38.65 | 37.66 | 30.25 |
APATM (%) | 27.50 | 26.44 | 32.63 | 32.97 | 24.59 |
ROCE (%) | 30.46 | 24.74 | 27.47 | 49.38 | 53.40 |
RONW (%) | 22.98 | 20.40 | 22.27 | 39.48 | 48.30 |